We don't know whether the most recent response to this request contains information or not – if you are A. I. Clayton please sign in and let everyone know.

Pfizer Covid 19 (BNT162b2) Vaccine

A. I. Clayton made this Freedom of Information request to Medicines and Healthcare Products Regulatory Agency Automatic anti-spam measures are in place for this older request. Please let us know if a further response is expected or if you are having trouble responding.

We're waiting for A. I. Clayton to read a recent response and update the status.

Dear Medicines and Healthcare Products Regulatory Agency,

The initial authorisation of the Pfizer Covid 19 (BNT162b2) vaccine product was given by Lord James Bethell (the Minister) in his capacity as licensing authority for such.

Please provide me with full details of the information which was provided to the Minister in order for him to proceed and grant such authorisation.

Yours faithfully,

A. I. Clayton

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

1 Attachment

Thank you for your email.  This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Experience
Centre Team. We will respond to you as soon as possible. 

 

Please note that we may not respond if your query: 

·         contains offensive language 

·         has already been answered in a previous reply to you 

·         is illegible 

·         is selling or promoting a product 

·         is for information only 

 

Kind regards

 

MHRA Customer Services Centre 

Medicines and Healthcare products Regulatory Agency 

10 South Colonnade, Canary Wharf, London E14 4PU 

[1][IMG][2]Medicines and Healthcare products Regulatory Agency

For information on how the Agency uses your personal data and your data
protection rights, please see our three centres' Privacy Notices: MHRA,
CPRD and NIBSC

 

DISCLAIMER This email and any files transmitted with it are confidential.
If you are not the intended recipient, any reading, printing, storage,
disclosure, copying or any other action taken in respect of this email is
prohibited and may be unlawful. If you are not the intended recipient,
please notify the sender immediately by using the reply function and then
permanently delete what you have received. Incoming and outgoing email
messages are routinely monitored for compliance with the Department of
Health's policy on the use of electronic communications. For more
information on the Department of Health's email policy, click
[3]DHTermsAndConditions

References

Visible links
1. http://www.gov.uk/mhra
2. http://www.gov.uk/mhra
3. https://www.gov.uk/help/terms-conditions

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Our Ref: FOI 24/189

Dear A I Clayton,

RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000

Thank you for your enquiry which we received on 26th February 2024.

I confirm that your request is now being handled under the Freedom of Information Act 2000 and you should receive a reply within 20 working days from our date of receipt.

If you need to contact us again about this request, please quote the reference number above.

Please be aware that we publish FOIs replies and these are redacted and are located on our website at the following link below.
https://www.gov.uk/government/collection...

Kind Regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf,
London E14 4PU

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

Dear A I Clayton,

We are writing to advise that we are working to finalise the response to your request, and we will not be able to meet the statutory 20 day time frame for response on this occasion; however, we are seeking to do this within the next 7 working days and will respond to you at that time. We apologise for this delay and any inconvenience caused.

Kind Regards,

MHRA Customer Experience Centre
Communications and engagement team
Medicines and Healthcare products Regulatory Agency
10 South Colonnade, Canary Wharf,
London E14 4PU

show quoted sections

MHRA Customer Services, Medicines and Healthcare Products Regulatory Agency

5 Attachments

Dear A I Clayton

 

Re: FOI 24/189

 

Please find attached the response and disclosure documents for your
request FOI 24/189. Please accept our apologies for the delay in issuing
this response to you.

 

Yours sincerely,

 

MHRA Customer Experience Centre

Communications and engagement team

Medicines and Healthcare products Regulatory Agency

10 South Colonnade, Canary Wharf, London E14 4PU

 

show quoted sections

We don't know whether the most recent response to this request contains information or not – if you are A. I. Clayton please sign in and let everyone know.